CAD & Hyperlipidemia Flashcards
type of lipoproteins within the body
- which are pro-atherosclerotic?
lipoproteins
- HDL
- LDL
- VLDL
- Chylomicrons
chylomicrons & LDL & VLDL are atherosclerotic – LDL is the most
indications for obtaining lipid profiles
- AHA/ACC recommendation for when to screen
- pediatrics: when to screen
- USPSTF –> men & women with RF, men & women W/O RF
AHA/ACC: screen ALL over the age of 20 for high blood cholesterol
Pediatrics: no clear guidlines on when to screen (consider if high genetic component or family history)
USPSTF
- those with cardiovascular risk factors: screen age 20+
- MEN without risk factors: screen at 35+
- women and men without risk factors ages 20-35: no guidelines
- consider Q5 year tests for low risk
- consdier Q3 year tests for near ot at treatment threshold
what is the goal of screening and obtaining lipid profile levels
(4)
- identify pts. with HIGH RISK lipid abnormalitlies due to family history
- idetify the cause of another condition (ex. pancreatitis)
- manage those with established ASCVD
- evaluate efficacy of treatment and lifestyle changes
what are the components of a lipid profile
- total cholesterol
- high density (HDL)
- low density (LDL)
- triglycerides
procedure for ordering a lipid profile
(why fasting?)
how long to follow up post starting treatment?
-most commonly order by a PCP
- want a FASTING panel: 8-12 hours of fasting prior to levels drawn
fasting level: because the triglycerides are heavily impacting by meals –> and the TG level goes into the determination of the LDL calculation & ultimate decision of treatment
- follow up 1 week after to discuss labs
- calculate the 10 year ASCVD risk score along with discussion fo lab levels
- primary treatment (lifestyle modification) & secondary (medication)
- re-evaluate after 6-8 weeks post medication
Total Cholesterol Values
- normal
- elevated/boarderline high
- high
Normal: < 200 mg/dL
elevated/boarderline: 200-239 mg/dL
High: 240 + mg/dL
high = initiate statin therapy
LDL levels
- optimal
- near optimal
- boarderline high
- high
- very high
what is the level we aim to acheive for those on statin therapy?
optimal: < 100 mg/dL
near optimal: 100-129 mg/dL
boarderline high: 130-159 mg/dL
high: 160-189 mg/dL
very high: 190+ mg/dL
Statin Therapy Goal: < 70
equation for measuring LDL from other lipid levels
LDL = total cholesterol - HDL - (TG/5)
HDl levels
- do you want low or high
- cut offs
want HIGHER HDL –> considered better, as lower levels increase risk fo ASCVD
low: < 40
high: > 60
explian the significance of the HDL to total cholesterol level ratio
- want higher or lower ratio? why?
- what is the equation
- the ratio of total cholesterol to HDl gives a better indication of risk profile for the pt.
TOTAL cholesterol/ HDL = ratio
ex. total = 240 HDl = 68 240/68 = 3.52 (low ratio)
WANT A LOWER RATIO… LOW RATIO = LOW RISK FOR CVD
Triglyceride level ranges
- normal
- mild increase
- moderate increase
- very high
normal: < 150 mg/dL
mild increase: 150-499
moderate increase: 500-886
very high: >886 risk for pancreatitis
what are some factors which may interfer with lipid profile numbers? specifically infleucen LDL levels
- if triglycerides are over 400 this will impact the LDL calculation
- high level of chlyomicrons in the blood (becuase chlyomicrons have lots of triglycerides – impacting the LDL calculatio)
- family history of type III hypercholesteremia (this condition increases their LDL levels
what is the clinical significance for
- LDL levels
- HDL levels
- higher LDL and low HDl = risk factors for CAD
- lowering LDL shown to reduce CVD events & mortality
- HDL levels alone are not a primary prevention target for reducing CAD
course of treatment for primary prevention od ASCVD
Priamry: those who have NOT already had an ASCVD event
- start high intensity statin when?
- start moderate for who? with what?
- consider moderatre for who & with what
HIGH INTENSITIY STATIN: begin for those with an LDL level > 190
Moderate intensity statin:
- for those who are 40-75 years with DM & LDL = >70
- for those 40-75 years withOUT DM & LDL = > 70 AND their ASCVD risk score > 7.5%
- alwasy consider the 10 year ASCVD score & the risk enhancer factors (inflammatory, CKD, metabolic syndrome, family hx.
course of treatment for those with secondary prevention
secondary: those who have HAD a ASCVD event in the past
- what is our target LDL
- those with very high risk ASCVD + statin but LDL > 70
- those on above but LDL > 70 still
target LDL: we want our pts. to be on the max. statin tolerated which lowers their LDL by 50%
those with very high risk ASCVD (had the event within past year) & already on a statin & their LDL is still > 70 = add ezetimbie
those on ezetimbie & high risk ASCVD & on statin with LDL > 70 = add PCSK9 inhibitor